Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8197694 | 0.99 | CHRM1 (0.59) | CHRM1CHRM2 | |
| SCHEMBL9544481 | 0.97 | CHRM1 (0.58) | CHRM1CHRM2 | |
| SCHEMBL8189296 | 0.97 | CHRM1 (0.58) | CHRM1CHRM2 | |
| SCHEMBL8196556 | 0.95 | CHRM1 (0.56) | CHRM1CHRM2 | |
| SCHEMBL7810641 | 0.94 | CHRM1 (0.55) | CHRM1CHRM2 | |
| SCHEMBL7810457 | 0.93 | CHRM2 (0.54) | CHRM1CHRM2 | |
| SCHEMBL7811583 | 0.93 | CHRM2 (0.54) | CHRM1CHRM2 | |
| SCHEMBL7811702 | 0.92 | CHRM1 (0.56) | CHRM1CHRM2 | |
| SCHEMBL4195842 | 0.92 | CHRM1 (0.56) | CHRM1CHRM2 | |
| SCHEMBL7810778 | 0.92 | CHRM1 (0.56) | CHRM1CHRM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0628041-B1 | HETEROCYCLIC COMPOUNDS AND THEIR PREPARATION AND USE | NOVO NORDISK AS (DK) | 2000-07-12 | — | — | EP | claimed |
| US-5414009-A | Cognition activators, analgesics; Alzheimer's disease, glaucoma | NOVO NORDISK A/S (DK) | 1995-05-09 | — | — | US | claimed |
| EP-0628041-A1 | HETEROCYCLIC COMPOUNDS AND THEIR PREPARATION AND USE | NOVO NORDISK A/S (DK) | 1994-12-14 | — | — | EP | claimed |
| WO-1993014089-A1 | HETEROCYCLIC COMPOUNDS AND THEIR PREPARATION AND USE | NOVO NORDISK A/S (DK) | 1993-07-22 | — | — | WO | claimed |
| WO-1993014090-A1 | HETEROCYCLIC COMPOUNDS AND THEIR PREPARATION AND USE | NOVO NORDISK A/S (DK) | 1993-07-22 | — | — | WO | claimed |
| EP-0628041-B1 | HETEROCYCLIC COMPOUNDS AND THEIR PREPARATION AND USE | NOVO NORDISK AS (DK) | 2000-07-12 | — | — | EP | disclosed |
| EP-0981558-A1 | HOMOPOLYMERS WITH HIGH PHOTOINDUCEABLE DOUBLE REFRACTION | Bayer Aktiengesellschaft (DE) | 2000-03-01 | — | — | EP | disclosed |
| US-5977129-A | ALZHEIMER'S DISEASE | NOVO NORDISK A/S (DK) | 1999-11-02 | — | — | US | disclosed |
| WO-1998051721-A1 | HOMOPOLYMERS WITH HIGH PHOTOINDUCEABLE DOUBLE REFRACTION | BAYER AKTIENGESELLSCHAFT (DE) | 1998-11-19 | — | — | WO | disclosed |
| US-5414009-A | Cognition activators, analgesics; Alzheimer's disease, glaucoma | NOVO NORDISK A/S (DK) | 1995-05-09 | — | — | US | disclosed |
| EP-0628041-A1 | HETEROCYCLIC COMPOUNDS AND THEIR PREPARATION AND USE | NOVO NORDISK A/S (DK) | 1994-12-14 | — | — | EP | disclosed |
| WO-1993014089-A1 | HETEROCYCLIC COMPOUNDS AND THEIR PREPARATION AND USE | NOVO NORDISK A/S (DK) | 1993-07-22 | — | — | WO | disclosed |
| WO-1993014090-A1 | HETEROCYCLIC COMPOUNDS AND THEIR PREPARATION AND USE | NOVO NORDISK A/S (DK) | 1993-07-22 | — | — | WO | disclosed |